Denali Therapeutics Inc. DNLI
Regular-session close
After hours · Nov 20, 4:52 PM ET
- YTD
- +11.75%
- 1 year
- +7.52%
Held by funds
129 US ETFs and mutual funds hold DNLI · largest positions
- IWM 0.09% of fund $70.57M
- VTI 0.00% of fund $68.36M
- NJM 0.08% of fund $65.81M
- VB 0.03% of fund $61.04M
- XBI 0.59% of fund $57.95M
- VWUSX 0.10% of fund $46.93M
- TCAF 0.31% of fund $39.45M
- FSSNX 0.11% of fund $38.28M
- VXF 0.04% of fund $34.50M
- VBK 0.08% of fund $34.20M
- FGCKX 0.03% of fund $30.03M
- IWN 0.18% of fund $24.15M
- NAJ 0.16% of fund $22.74M
- IBB 0.20% of fund $21.56M
- DFAS 0.06% of fund $20.85M
- VTWO 0.09% of fund $16.38M
- SCHA 0.07% of fund $15.38M
- FSMAX 0.04% of fund $15.20M
- DFMC 0.13% of fund $9.81M
- ACFNX 0.44% of fund $9.32M
Ownership
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 12.24% | 19,617,453 | 361.55M | Sep 29, 2026 |
| Blackrock Inc. | 8.94% | 14,328,688 | 264.08M | Sep 29, 2026 |
| BAILLIE GIFFORD & CO | 6.94% | 11,119,945 | 204.94M | Sep 29, 2026 |
| Temasek Holdings (Private) Ltd | 4.38% | 7,012,974 | 129.25M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 4.22% | 6,758,410 | 124.56M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.21% | 6,751,225 | 124.43M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App | 3.10% | 4,966,700 | 91.54M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.68% | 4,288,391 | 79.04M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.38% | 3,813,515 | 70.28M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.93% | 3,097,183 | 57.08M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.91% | 3,055,331 | 56.31M | Sep 29, 2026 |
| VANGUARD WORLD FUND-Vanguard U.S. Growth Fund | 1.67% | 2,681,184 | 49.41M | Aug 30, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs DNLI, and what each was last paid
Ryan J. Watts, Co-Founder, President, Chief Executive Officer & DirectorAverage age 54
| Name | Title | Pay | Age |
|---|---|---|---|
| Ryan J. Watts | Co-Founder, President, Chief Executive Officer & Director | $1.42M | 50 |
| Alexander O. Schuth | Co-Founder, Chief Financial Officer, Chief Operating Officer & Secretary | $926K | 53 |
| Chris Walsh | General Counsel | — | — |
| Joe Lewcock | Chief Scientific Officer | — | — |
| Cindy Dunkle | Chief People Officer | — | — |
| Katie Peng | Chief Commercial Officer | — | 55 |
| Dana Andersen | Chief Technical and Manufacturing Officer | — | — |
| Peter Chin | Acting Chief Medical Officer & Head of Development | — | 58 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAKER BROS ADVISORS, L.P. | Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jun 2, 2026 | 0 |
| CHIN PETER SCOTT | Officer | Sale | Sep 3, 2026 | 204,538 |
| FLATLEY JAY T | Director | Stock Award(Grant) | Jun 2, 2026 | 358,941 |
| HO CAROLE | Officer | Sale | Aug 12, 2025 | 424,804 |
| KROGNES STEVE E | Director | Stock Award(Grant) | Jun 2, 2026 | 819,999 |
| SATO VICKI LEE | Director | Sale | Jan 1, 2025 | 107,976 |
